Ghana Health Ministry: Urges Validated Traditional Medicine Integration

• Ghana's Deputy Health Minister, Prof. Dr. Grace Ayensu-Danquah, advocates for integrating scientifically validated traditional medicine into mainstream healthcare.
• This integration requires robust research, stringent regulation, and adherence to approved manufacturing standards, including Good Manufacturing Practices (GMP).
• The Ministry of Health aims to foster collaboration between traditional and conventional medicine sectors to improve healthcare outcomes and ensure product safety and quality.
• The government's Free Primary Healthcare programme offers an avenue for traditional medicine to contribute, particularly in managing non-communicable diseases like hypertension and diabetes, subject to scientific validation.
• Industry players, such as COA Research and Manufacturing Company, are actively engaged in research to validate traditional medicine products and support the sector's development.

The broader objective is to create a healthcare system in which traditional and conventional medicine could complement each other safely, based on scientific evidence and appropriate regulatory standards.

Ghana's Deputy Minister for Health, Professor Dr. Grace Ayensu-Danquah, has issued a call for the enhanced integration of scientifically validated traditional medicine into the nation's primary healthcare system. This initiative underscores a strategic move to leverage traditional practices, provided they meet rigorous standards, to broaden access to safe and high-quality medical care across the country.

During a visit to the Centre of Awareness (COA) Research and Manufacturing Company in the Central Region, Professor Ayensu-Danquah engaged with the company's leadership and staff. Her inspection of the facilities focused on assessing their adherence to Good Manufacturing Practices (GMP), signaling the Ministry's commitment to ensuring product quality and safety within the traditional medicine sector. The Deputy Minister highlighted that traditional medicine, when subjected to proper research, stringent regulation, and manufacturing according to approved standards, possesses significant potential to contribute to public health.

A core tenet of the Ministry's vision is the establishment of a robust framework for the scientific validation and regulation of traditional medicine. Professor Ayensu-Danquah specifically identified non-communicable diseases, such as hypertension and diabetes, as areas where traditional medicine could offer valuable contributions. However, she stressed that any such integration would be contingent upon rigorous scientific validation and the implementation of appropriate regulatory oversight.

This emphasis on scientific evidence and regulatory compliance is central to the broader objective of creating a healthcare system where both traditional and conventional medicine can safely complement each other. The Ministry of Health has committed to ongoing collaboration with relevant stakeholders to fortify research capabilities, enhance quality assurance processes, improve manufacturing standards, and strengthen the regulatory environment within the traditional medicine sector. This comprehensive approach aims to build public trust and ensure the reliability of traditional medical products and practices.

The government's Free Primary Healthcare programme, which prioritizes preventive and promotive healthcare, presents a significant opportunity to explore how traditional medicine can contribute effectively to primary healthcare delivery. This policy alignment suggests a strategic pathway for integrating traditional practices into broader public health initiatives, particularly those focused on community-level wellness and disease prevention.

Professor (HC) Samuel Ato Duncan, CEO of COA Manufacturing Company, expressed strong support for the government's efforts to elevate the traditional medicine sector. He noted that developing the sector to meet national standards would enable it to effectively complement existing national healthcare programmes, including the Free Primary Healthcare initiative. This industry perspective highlights a shared vision for a more integrated and comprehensive healthcare landscape in Ghana.

COA Manufacturing Company is actively engaged in research to investigate the potential health benefits of its products, including their possible applications in the management of cancer and viral diseases. This commitment to scientific inquiry from industry players is crucial for generating the evidence base required for broader acceptance and integration of traditional medicines.

Professor Duncan underscored the critical importance of sustained research and collaborative efforts involving traditional medicine practitioners, scientific researchers, and government institutions. He articulated that such collaborative endeavors are essential for unlocking the full potential of the sector, strengthening the evidence supporting traditional medicines, and ultimately enabling them to make a greater contribution to healthcare delivery across Ghana.

Lawyers and compliance officers in Ghana's healthcare and pharmaceutical sectors should closely monitor upcoming legislative and regulatory developments concerning the integration, manufacturing standards, and scientific validation of traditional medicines, as new compliance requirements and market opportunities are likely to emerge.

Source: Original reporting via Myjoyonline.com